These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32912767)

  • 21. Differential effects of follicle-stimulating and luteinizing hormones on testosterone production by mouse testes.
    Dalterio SL; Suter DE; Schwartz NB; Mayfield D; Rettori VB
    J Steroid Biochem; 1986 Jul; 25(1):149-56. PubMed ID: 3091938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new male hypogonadism mutant rat (hgn/hgn): concentrations of testosterone (T), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in the serum and the responsiveness of accessory sex organs to exogenous T, FSH, human chorionic gonadotropin, and luteinizing hormone-releasing hormone.
    Hakamata Y; Kikukawa K; Kamei T; Suzuki K; Taya K; Sasamoto S
    Biol Reprod; 1988 Jun; 38(5):1145-53. PubMed ID: 3136809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
    Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
    Thau R
    Scand J Immunol Suppl; 1992; 11():127-30. PubMed ID: 1514027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum prolactin, FSH, LH and testosterone before and after vasectomy in normal men.
    Nikkanen V; Punnonen R
    Arch Androl; 1982 Jun; 8(4):311-3. PubMed ID: 6810776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancer.
    Murthy V; Norman AR; Barbachano Y; Parker CC; Dearnaley DP
    BJU Int; 2007 Jun; 99(6):1380-2. PubMed ID: 17537213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of oestrogen administration on plasma testosterone, FSH and LH levels in patients with Klinefelter's syndrome and normal men.
    Smals AG; Kloppenborg PW; Lequin RM; Benraad TJ
    Acta Endocrinol (Copenh); 1974 Dec; 77(4):765-83. PubMed ID: 4479709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
    Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
    J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of serum immunoreactive luteinizing hormone and bioactive follicle-stimulating hormone by testosterone in early pubertal boys.
    Hassing JM; Padmanabhan V; Kelch RP; Brown MB; Olton PR; Sonstein JS; Foster CM; Beitins IZ
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1082-9. PubMed ID: 2108181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum luteinizing hormone pulsatility and intratesticular testosterone and oestradiol concentrations in idiopathic infertile men with high and normal follicle stimulating hormone serum concentrations.
    Levalle OA; Zylbersztein C; Aszpis S; Mariani V; Ponzio R; Aranda C; Guitelman A; Scaglia HE
    Hum Reprod; 1994 May; 9(5):781-7. PubMed ID: 7929722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.
    Gross KM; Matsumoto AM; Southworth MB; Bremner WJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):197-202. PubMed ID: 3917266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.
    Jockenhövel F; Vogel E; Kreutzer M; Reinhardt W; Lederbogen S; Reinwein D
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luteinizing Hormone Suppression Profiles in Men Treated With Exogenous Testosterone.
    Miranda EP; Schofield E; Matsushita K; Katz DJ; Nelson CJ; Benfante N; Mulhall JP
    J Sex Med; 2022 Sep; 19(9):1359-1365. PubMed ID: 35842309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progesterone secretion by granulosa cells from rats with four- or five-day estrous cycles: the development of responses to follicle-stimulating hormone, luteinizing hormone, and testosterone.
    Quirk SM; Hilbert JL; Fortune JE
    Endocrinology; 1986 Jun; 118(6):2402-10. PubMed ID: 3084218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
    Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
    Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.